A massively parallel CRISPR-based screening platform for modifiers of neuronal depolarization
11 affiliations
- 1Institute for Neurodegenerative Diseases, University of California, San Francisco, San Francisco, CA, USA
- 2Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA
- 3Department of Neuroscience, Genentech, South San Francisco, CA, USA
- 4Biological and Medical Informatics Graduate Program, University of California, San Francisco, San Francisco, CA, USA
- 5City College of San Francisco, San Francisco, CA, USA
- 6Department of Functional Genomics, Genentech, South San Francisco, CA, USA
- 7Medical Scientist Training Program, University of California, San Francisco, San Francisco, CA, USA
- 8Neuroscience Graduate Program, University of California, San Francisco, San Francisco, CA, USA
- 9Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA, USA. [email protected]
- 10Institute for Neurodegenerative Diseases, University of California, San Francisco, San Francisco, CA, USA. [email protected]
- 11Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA. [email protected]
Abstract
Understanding the complex interplay between gene expression and neuronal activity is crucial for unraveling the molecular mechanisms underlying cognitive function and neurological disorders. Here, we developed pooled screens using CRISPR interference (CRISPRi) and the fluorescent calcium integrator CaMPARI2 to evaluate genetic modifiers of neuronal depolarization. Using this screening method, we evaluated 1343 genes for their effect on depolarization in a human iPSC-derived neuron model, revealing potential links to neurodegenerative and neurodevelopmental disorders. These genes include known regulators of neuronal excitability, such as TARPs and ion channels, as well as genes associated with autism spectrum disorder and Alzheimer's disease not previously described to affect neuronal depolarization. This CRISPRi-based screening platform offers a versatile tool to uncover molecular mechanisms controlling neuronal function in health and disease.
Related
- LOOP-TAG: massively-parallel measurement of length-dependent protein-mediated DNA looping probabilities by tagmentation in vitro
- Massively parallel quantification and prediction of monomeric protein yield in Escherichia coli
- A Proximity-Driven Functional Screening Platform for the Discovery of Noninhibitory USP7 Ligand Enabling Targeted Protein Stabilization
- An activity‑based high‑throughput screening platform for identifying functional modulators of OFF‑type riboswitches
- A Collective CRISPR-Cas12a Biosensing Platform for Effect-Based Screening of Pesticide Residues.
BibTeX
@article{boggess2026massively,
title = {{A massively parallel CRISPR-based screening platform for modifiers of neuronal depolarization}},
author = {Steven C. Boggess and Vaidehi Gandhi and Ming‐Chi Tsai and Emily Marzette and Noam Teyssier and Joanna Yu-Ying Chou and Xiaoyu Hu and Amber L. Cramer and Lin Yadanar and Kunal Shroff and Claire G. Jeong and Céline Eidenschenk and Jesse E. Hanson and Ruilin Tian and Martin Kampmann},
journal = {Nature Communications},
year = {2026},
month = aug,
doi = {10.1038/s41467-026-75882-0},
url = {https://doi.org/10.1038/s41467-026-75882-0},
note = {CC BY},
}
RIS
TY - JOUR
TI - A massively parallel CRISPR-based screening platform for modifiers of neuronal depolarization
AU - Steven C. Boggess
AU - Vaidehi Gandhi
AU - Ming‐Chi Tsai
AU - Emily Marzette
AU - Noam Teyssier
AU - Joanna Yu-Ying Chou
AU - Xiaoyu Hu
AU - Amber L. Cramer
AU - Lin Yadanar
AU - Kunal Shroff
AU - Claire G. Jeong
AU - Céline Eidenschenk
AU - Jesse E. Hanson
AU - Ruilin Tian
AU - Martin Kampmann
PY - 2026
DA - 2026/08/01
JO - Nature Communications
DO - 10.1038/s41467-026-75882-0
UR - https://doi.org/10.1038/s41467-026-75882-0
AB - Understanding the complex interplay between gene expression and neuronal activity is crucial for unraveling the molecular mechanisms underlying cognitive function and neurological disorders. Here, we developed pooled screens using CRISPR interference (CRISPRi) and the fluorescent calcium integrator CaMPARI2 to evaluate genetic modifiers of neuronal depolarization. Using this screening method, we evaluated 1343 genes for their effect on depolarization in a human iPSC-derived neuron model, revealing potential links to neurodegenerative and neurodevelopmental disorders. These genes include known regulators of neuronal excitability, such as TARPs and ion channels, as well as genes associated with autism spectrum disorder and Alzheimer's disease not previously described to affect neuronal depolarization. This CRISPRi-based screening platform offers a versatile tool to uncover molecular mechanisms controlling neuronal function in health and disease.
SN - 2041-1723
ER -